Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Content by Intermountain Health Regional Communications. Did you know that raising awareness and encouraging screening can ...

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...

6 Around 80-85% of all lung cancers are non-small cell lung cancer (NSCLC) 7, and most cases of lung cancer in non-smokers ...

SINGAPORE: A local study has unveiled a promising treatment approach for Non-Small Cell Lung Cancer (NSCLC), the most common ...

Following mixed study results, the partners have backed away from seeking broad clearance of dato-dxd in lung cancer and ...

Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.

The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

An increasing number of non-smokers are being diagnosed with lung cancer for a variety of reasons. To better understand this ...